Rona Therapeutics has garnered $33 million in a Series A round of financing. In a separate development, Chinese genomics company Singleron Biotechnologies has acquired Singapore’s Proteona.
Rona Therapeutics raises $33m Series A
RNA therapeutics platform Rona Therapeutics has raised $33 million in a Series A round of financing, per a company statement on Thursday.
